Drug Type siRNA |
Synonyms- |
Target |
Action inhibitors |
Mechanism C3 inhibitors(Complement C3 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Complement Factor H Deficiency | Preclinical | China | 30 Jan 2024 | |
Glomerulonephritis, IGA | Preclinical | China | 30 Jan 2024 | |
Hemoglobinuria, Paroxysmal | Preclinical | China | 30 Jan 2024 |